Yayın:
A Deeper Insight into COL4A3, COL4A4, and COL4A5 Variants and Genotype-Phenotype Correlation of a Turkish Cohort with Alport Syndrome

dc.contributor.authorYavas, Cueneyd
dc.contributor.authorOzgenturk, Nehir Ozdemir
dc.contributor.authorDogan, Mustafa
dc.contributor.authorGezdirici, Alper
dc.contributor.authorKeskin, Ece
dc.contributor.authorIli, Ezgi Gokpinar
dc.contributor.authorDogan, Tunay
dc.contributor.authorCelebi, Evrim
dc.contributor.authorBender, Onur
dc.contributor.authorUn, Cemal
dc.date.accessioned2026-06-27T14:56:08Z
dc.date.issued2023
dc.description.abstractIntroduction: Alport syndrome (AS) is an inherited, rare, progressive kidney disease that affects the eye and ear physiology. Pathogenic variants of COL4A5 account for 85% of all cases, while COL4A3 and COL4A4 account for the remaining 15%. Methods: Targeted next-generation sequencing of the COL4A3, COL4A4, and COL4A5 genes was performed in 125 Turkish patients with AS. The patients were compared to 45 controls and open-access population data. Results: The incidence of AS variants in patients was found as 21.6%. 27 variants were identified as pathogenic/likely pathogenic, 28 as variant of uncertain significance, and 52 as benign/likely benign. We also found 31 novel variants (14 in COL4A3, 6 in COL4A4, and 11 in COL4A5) of which 27 were classified as pathogenic/likely pathogenic. Pathogenic/likely Pathogenic variants were most commonly found in the COL4A5 gene, consistent with the literature. This study contributed novel variants associated with AS to the literature. Conclusion: Genetic testing is a crucial part for the diagnosis and management of AS. Studies on the genetic etiology of AS are limited for the Turkish population. We believe that this study will contribute to the literature and the clinical decision-making process of patients with AS and emphasize the importance of genetic counseling.(c) 2023en
dc.description.urihttps://doi.org/10.1159/000533915
dc.identifier.doi10.1159/000533915
dc.identifier.eissn1661-8777
dc.identifier.endpage13
dc.identifier.issn1661-8769
dc.identifier.issue1
dc.identifier.pubmed38357258
dc.identifier.startpage1
dc.identifier.urihttps://hdl.handle.net/20.500.14981/66420
dc.identifier.volume15
dc.identifier.wos001095960400001
dc.language.isoeng
dc.publisherKARGER
dc.relation.ispartofMOLECULAR SYNDROMOLOGY
dc.rightsopenAccess
dc.subjectNext-generation sequencing
dc.subjectAlport syndrome
dc.subjectKidney disease
dc.subjectNovel variants
dc.subjectGenome
dc.subjectNATURAL-HISTORY
dc.subjectDIGENIC INHERITANCE
dc.subjectMUTATIONS
dc.subjectNEPHROPATHIES
dc.subjectDIAGNOSIS
dc.subjectFAMILIES
dc.subjectSPECTRUM
dc.subjectFEATURES
dc.subjectIMPACT
dc.subjectGENES
dc.subjectGenetics & Heredity
dc.titleA Deeper Insight into COL4A3, COL4A4, and COL4A5 Variants and Genotype-Phenotype Correlation of a Turkish Cohort with Alport Syndrome
dc.typeArticle
dspace.entity.typePublication
local.import.sourceWOS

Dosyalar

Koleksiyonlar